Vitamin D Is Required for IFN-γ–Mediated Antimicrobial Activity of Human Macrophages

Vitamin D is required for both innate and adaptive immunity to tuberculosis. The Sunny Side of Antimicrobial Response Nearly one-third of the world’s population is thought to be infected with Mycobacterium tuberculosis, which causes a potentially fatal lung disease in untreated patients. Although most M. tuberculosis infections can be treated by antibiotic therapy, the burden of infection is especially high in immunodeficient (HIV+) patients and individuals from developing nations. Moreover, drug-resistant M. tuberculosis is increasingly prevalent. Yet, most humans with M. tuberculosis infection are asymptomatic, perhaps because of successful immunological control. Understanding the mechanisms behind immune control of M. tuberculosis infection may pinpoint potential new therapeutic avenues. Now, Fabri et al. examine the antimicrobial function of M. tuberculosis–infected human macrophages. The authors found that cells from the adaptive immune system—T cells—governed bacterial control by releasing the cytokine interferon-γ (IFN-γ), which then activated infected macrophages, inciting the cells to attack the invading M. tuberculosis. This activation depended on the presence of vitamin D, a fat-soluble prohormone thought to be beneficial for everything from bone health to cancer therapy. Indeed, this antimicrobial response was not seen with macrophages maintained in human sera from subjects with insufficient vitamin D levels. Vitamin D3 has been used historically to treat M. tuberculosis infection, but its effects have not been thoroughly tested in clinical trials. This study suggests that increasing serum levels of vitamin D, whether through supplementation or increased sun exposure, should improve the human immune response to M. tuberculosis and supports further testing of vitamin D in the clinic. Control of tuberculosis worldwide depends on our understanding of human immune mechanisms, which combat the infection. Acquired T cell responses are critical for host defense against microbial pathogens, yet the mechanisms by which they act in humans remain unclear. We report that T cells, by the release of interferon-γ (IFN-γ), induce autophagy, phagosomal maturation, the production of antimicrobial peptides such as cathelicidin, and antimicrobial activity against Mycobacterium tuberculosis in human macrophages via a vitamin D–dependent pathway. IFN-γ induced the antimicrobial pathway in human macrophages cultured in vitamin D–sufficient sera, but not in sera from African-Americans that have lower amounts of vitamin D and who are more susceptible to tuberculosis. In vitro supplementation of vitamin D–deficient serum with 25-hydroxyvitamin D3 restored IFN-γ–induced antimicrobial peptide expression, autophagy, phagosome-lysosome fusion, and antimicrobial activity. These results suggest a mechanism in which vitamin D is required for acquired immunity to overcome the ability of intracellular pathogens to evade macrophage-mediated antimicrobial responses. The present findings underscore the importance of adequate amounts of vitamin D in all human populations for sustaining both innate and acquired immunity against infection.

[1]  J. Casanova,et al.  Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease , 2011, Nature Immunology.

[2]  R. Wilkinson,et al.  High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial , 2011, The Lancet.

[3]  J. Adams,et al.  T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism , 2010, Proceedings of the National Academy of Sciences.

[4]  J. Parsonnet,et al.  Vitamin D Deficiency and Tuberculosis Progression , 2010, Emerging infectious diseases.

[5]  Sarman Singh,et al.  Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis , 2010, Cell.

[6]  J. Son,et al.  Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-γ in Human Macrophages after Mycobacterial Infection , 2009, Immune network.

[7]  S. Anderson,et al.  Association between Gc genotype and susceptibility to TB is dependent on vitamin D status , 2009, European Respiratory Journal.

[8]  D. Shin,et al.  Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. , 2009, Cell host & microbe.

[9]  M. Pypaert,et al.  Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P2 and PtdIns(3,4,5)P3 promotes immunity to mycobacteria , 2009, Nature Immunology.

[10]  G. Cheng,et al.  Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses , 2009, PloS one.

[11]  T. Ziegler,et al.  Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  K. Leder,et al.  The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. , 2009, The American journal of tropical medicine and hygiene.

[13]  J. Adams,et al.  IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway , 2008, The Journal of Immunology.

[14]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[15]  R. Modlin,et al.  Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin1 , 2007, The Journal of Immunology.

[16]  Peter J. Peters,et al.  M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells , 2007, Cell.

[17]  S. Alonso,et al.  Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy , 2007, Proceedings of the National Academy of Sciences.

[18]  M. Lipinski,et al.  Autophagy Limits Listeria monocytogenes Intracellular Growth in the Early Phase of Primary Infection , 2007, Autophagy.

[19]  V. Deretic,et al.  Human IRGM Induces Autophagy to Eliminate Intracellular Mycobacteria , 2006, Science.

[20]  J. Adams,et al.  Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response , 2006, Science.

[21]  H. Koeffler,et al.  Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  T. Graeber,et al.  TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells , 2005, Nature Medicine.

[23]  R. Wilkinson,et al.  Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. , 2005, The Journal of infection.

[24]  Hiroshi Sagara,et al.  Escape of Intracellular Shigella from Autophagy , 2005, Science.

[25]  V. Deretic,et al.  Autophagy Is a Defense Mechanism Inhibiting BCG and Mycobacterium tuberculosis Survival in Infected Macrophages , 2004, Cell.

[26]  S. Hamada,et al.  Autophagy Defends Cells Against Invading Group A Streptococcus , 2004, Science.

[27]  S. Fortune,et al.  Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.

[28]  P. Nibbering,et al.  Expression of β‐defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells , 2002 .

[29]  M. Cogswell,et al.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.

[30]  S. Akira,et al.  [Induction of direct antimicrobial activity through mammalian toll-like receptors]. , 2001, Pneumologie.

[31]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[32]  B. Britigan,et al.  Gallium Disrupts Iron Metabolism of Mycobacteria Residing within Human Macrophages , 2000, Infection and Immunity.

[33]  C. Carlberg,et al.  Antagonistic Action of a 25-Carboxylic Ester Analogue of 1α,25-Dihydroxyvitamin D3 Is Mediated by a Lack of Ligand-induced Vitamin D Receptor Interaction with Coactivators* , 2000, The Journal of Biological Chemistry.

[34]  R. Wilkinson,et al.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.

[35]  L. Ting,et al.  Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.

[36]  B. Bloom,et al.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.

[37]  M. Zucca,et al.  Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. , 1999, Blood.

[38]  S. Dorman,et al.  A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.

[39]  H. Kraemer,et al.  Ethnic variation in cardiovascular disease risk factors among children and young adults: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 1999, JAMA.

[40]  T. Ganz,et al.  An antimicrobial activity of cytolytic T cells mediated by granulysin. , 1998, Science.

[41]  B. Dawson-Hughes,et al.  Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. , 1998, The American journal of clinical nutrition.

[42]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[43]  J. Ho,et al.  Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-gamma and primed lymphocytes. , 1998, Journal of immunology.

[44]  J. Ellner,et al.  Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T cells in purified protein derivative-positive, but not in purified protein derivative-negative subjects. , 1998, Journal of immunology.

[45]  M. Newport,et al.  A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. , 1996, The New England journal of medicine.

[46]  F. Leutmezer,et al.  Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1α,25‐dihydroxyvitamin D3 and cytokines , 1995, Journal of leukocyte biology.

[47]  K. Tanaka,et al.  Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[48]  P. Schlesinger,et al.  Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. , 1994, Science.

[49]  B. Bloom,et al.  Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages , 1993, Infection and immunity.

[50]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[51]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[52]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[53]  P. Andrew,et al.  Interferon gamma fails to activate human monocyte-derived macrophages to kill or inhibit the replication of a non-pathogenic mycobacterial species. , 1991, Microbial pathogenesis.

[54]  M. Denis Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol , 1991, Clinical and experimental immunology.

[55]  B. Hollis,et al.  Racial pigmentation and the cutaneous synthesis of vitamin D. , 1991, Archives of dermatology.

[56]  W. Stead,et al.  Racial differences in susceptibility to infection by Mycobacterium tuberculosis. , 1990, The New England journal of medicine.

[57]  G. Rook,et al.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. , 1987, Immunology.

[58]  B. Champion,et al.  Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. , 1986, Immunology.

[59]  A. J. Crowle,et al.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria , 1985, Infection and immunity.

[60]  R. Brown,et al.  A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. , 1985, Tubercle.

[61]  J. Adams,et al.  Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis , 1985, The Journal of experimental medicine.

[62]  J. Adams,et al.  INCREASED SKIN PIGMENT REDUCES THE CAPACITY OF SKIN TO SYNTHESISE VITAMIN D3 , 1982, The Lancet.

[63]  P. D. Hart,et al.  RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES , 1971, The Journal of experimental medicine.

[64]  W. Loomis Skin-Pigment Regulation of Vitamin-D Biosynthesis in Man , 1967, Science.

[65]  B. Bloom,et al.  Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.

[66]  M. Boyde,et al.  A Systematic Review of Randomized Controlled Trials , 2011 .

[67]  G. Schoolnik,et al.  Genome-wide expression profiling of intracellular bacteria: The interaction of Mycobacterium tuberculosis with macrophages , 2002 .

[68]  Ichael,et al.  A MUTATION IN THE INTERFERON- g –RECEPTOR GENE AND SUSCEPTIBILITY TO MYCOBACTERIAL INFECTION , 2000 .

[69]  D. Havlir,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1999, The New England journal of medicine.

[70]  G. Rook,et al.  Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.

[71]  P. Prandoni,et al.  A Case-Control Study , 2022 .